"","ID","Description","GeneRatio","BgRatio","pvalue","p.adjust","qvalue","geneID","Count"
"R-HSA-212436","R-HSA-212436","Generic Transcription Pathway","23/35","481/2914",7.49952594177545e-11,3.24729473278877e-08,2.12354997719747e-08,"MYB/MAPK3/ESR1/CDK5/MAPK1/CSNK2A1/CDK2/AKT2/MAF/STK11/SMAD2/SP1/SMAD3/YAP1/HDAC1/AKT3/PARP1/SMAD4/AKT1/RBL1/E2F4/STAT1/AXIN1",23
"R-HSA-73857","R-HSA-73857","RNA Polymerase II Transcription","23/35","499/2914",1.63608290324719e-10,3.54211948553017e-08,2.31634895249208e-08,"MYB/MAPK3/ESR1/CDK5/MAPK1/CSNK2A1/CDK2/AKT2/MAF/STK11/SMAD2/SP1/SMAD3/YAP1/HDAC1/AKT3/PARP1/SMAD4/AKT1/RBL1/E2F4/STAT1/AXIN1",23
"R-HSA-8878166","R-HSA-8878166","Transcriptional regulation by RUNX2","10/35","62/2914",1.09224085001227e-09,1.57646762685105e-07,1.03092206545018e-07,"MAPK3/ESR1/MAPK1/AKT2/MAF/YAP1/AKT3/SMAD4/AKT1/STAT1",10
"R-HSA-2173793","R-HSA-2173793","Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer","8/35","36/2914",4.41833732094092e-09,4.78285014991854e-07,3.12771773508712e-07,"SMAD2/SP1/SMAD3/HDAC1/PARP1/SMAD4/RBL1/E2F4",8
"R-HSA-2173796","R-HSA-2173796","SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription","7/35","24/2914",5.73365428313890e-09,4.96534460919828e-07,3.24705895192497e-07,"SMAD2/SP1/SMAD3/HDAC1/SMAD4/RBL1/E2F4",7
"R-HSA-9614085","R-HSA-9614085","FOXO-mediated transcription","8/35","49/2914",5.90737270435002e-08,4.26315396830593e-06,2.78786536398273e-06,"AKT2/STK11/SMAD2/SMAD3/HDAC1/AKT3/SMAD4/AKT1",8
"R-HSA-8939211","R-HSA-8939211","ESR-mediated signaling","10/35","108/2914",2.72209294322803e-07,1.68380892059677e-05,1.10111729583209e-05,"MYB/MAPK3/ESR1/MAPK1/AKT2/SP1/HDAC1/AKT3/AKT1/AXIN1",10
"R-HSA-170834","R-HSA-170834","Signaling by TGF-beta Receptor Complex","8/35","63/2914",4.51196034115287e-07,2.44209853464899e-05,1.59699648917121e-05,"SMAD2/SP1/SMAD3/HDAC1/PARP1/SMAD4/RBL1/E2F4",8
"R-HSA-5663202","R-HSA-5663202","Diseases of signal transduction","14/35","268/2914",8.77321245777404e-07,4.22088999357351e-05,2.76022707735815e-05,"MAPK3/ESR1/GSK3A/MAPK1/AKT2/STAT3/SMAD2/SMAD3/HDAC1/AKT3/SMAD4/AKT1/STAT1/AXIN1",14
"R-HSA-9006931","R-HSA-9006931","Signaling by Nuclear Receptors","10/35","136/2914",2.38330717538877e-06,9.97494851507572e-05,6.52306101994741e-05,"MYB/MAPK3/ESR1/MAPK1/AKT2/SP1/HDAC1/AKT3/AKT1/AXIN1",10
"R-HSA-2173795","R-HSA-2173795","Downregulation of SMAD2/3:SMAD4 transcriptional activity","5/35","20/2914",2.534051585816e-06,9.97494851507572e-05,6.52306101994741e-05,"SMAD2/SMAD3/HDAC1/PARP1/SMAD4",5
"R-HSA-6807070","R-HSA-6807070","PTEN Regulation","7/35","59/2914",4.19555601835012e-06,0.0001513896463288,9.90004007838757e-05,"MAPK3/MAPK1/CSNK2A1/AKT2/HDAC1/AKT3/AKT1",7
"R-HSA-69206","R-HSA-69206","G1/S Transition","7/35","60/2914",4.70931420459814e-06,0.000156856388506999,0.000102575345832947,"CDK2/AKT2/HDAC1/AKT3/AKT1/RBL1/E2F4",7
"R-HSA-9006936","R-HSA-9006936","Signaling by TGF-beta family members","8/35","86/2914",5.09517938804429e-06,0.000157586619644513,0.000103052876344655,"SMAD2/SP1/SMAD3/HDAC1/PARP1/SMAD4/RBL1/E2F4",8
"R-HSA-8941326","R-HSA-8941326","RUNX2 regulates bone development","5/35","24/2914",6.71115572669813e-06,0.000181620651853768,0.000118769795426434,"MAPK3/MAPK1/MAF/YAP1/SMAD4",5
"R-HSA-9634638","R-HSA-9634638","Estrogen-dependent nuclear events downstream of ESR-membrane signaling","5/35","24/2914",6.71115572669813e-06,0.000181620651853768,0.000118769795426434,"MAPK3/MAPK1/AKT2/AKT3/AKT1",5
"R-HSA-69278","R-HSA-69278","Cell Cycle, Mitotic","11/35","191/2914",7.48504391148784e-06,0.000190648471392602,0.000124673486822924,"MAPK3/MAPK1/CSNK2A1/CDK2/AKT2/CSNK1D/HDAC1/AKT3/AKT1/RBL1/E2F4",11
"R-HSA-5633007","R-HSA-5633007","Regulation of TP53 Activity","8/35","95/2914",1.08193228409824e-05,0.000260264821674744,0.000170198704340601,"CDK5/CSNK2A1/CDK2/AKT2/STK11/HDAC1/AKT3/AKT1",8
"R-HSA-198323","R-HSA-198323","AKT phosphorylates targets in the cytosol","4/35","13/2914",1.1561382273477e-05,0.000263477817074503,0.000172299824463453,"GSK3A/AKT2/AKT3/AKT1",4
"R-HSA-6804758","R-HSA-6804758","Regulation of TP53 Activity through Acetylation","4/35","14/2914",1.60480880476759e-05,0.000347441106232183,0.000227207141306569,"AKT2/HDAC1/AKT3/AKT1",4
"R-HSA-109606","R-HSA-109606","Intrinsic Pathway for Apoptosis","6/35","49/2914",1.85316808719628e-05,0.000378129413773181,0.000247275586009446,"MAPK3/MAPK1/AKT2/STAT3/AKT3/AKT1",6
"R-HSA-1266738","R-HSA-1266738","Developmental Biology","15/35","397/2914",1.92121180208083e-05,0.000378129413773181,0.000247275586009446,"MYB/MAPK3/CEBPB/CDK5/MAPK1/CSNK2A1/CDK2/AKT2/PAK1/STAT3/SMAD2/SMAD3/AKT3/SMAD4/AKT1",15
"R-HSA-453279","R-HSA-453279","Mitotic G1-G1/S phases","7/35","77/2914",2.53575474893884e-05,0.000477383394039356,0.000312182163599336,"CDK2/AKT2/HDAC1/AKT3/AKT1/RBL1/E2F4",7
"R-HSA-3700989","R-HSA-3700989","Transcriptional Regulation by TP53","10/35","194/2914",5.74104897597708e-05,0.000954837079591957,0.00062441029393518,"CDK5/CSNK2A1/CDK2/AKT2/STK11/HDAC1/AKT3/AKT1/RBL1/E2F4",10
"R-HSA-1538133","R-HSA-1538133","G0 and Early G1","4/35","19/2914",5.95394945703991e-05,0.000954837079591957,0.00062441029393518,"CDK2/HDAC1/RBL1/E2F4",4
"R-HSA-8940973","R-HSA-8940973","RUNX2 regulates osteoblast differentiation","4/35","19/2914",5.95394945703991e-05,0.000954837079591957,0.00062441029393518,"MAPK3/MAPK1/MAF/YAP1",4
"R-HSA-9615017","R-HSA-9615017","FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes","4/35","19/2914",5.95394945703991e-05,0.000954837079591957,0.00062441029393518,"SMAD2/SMAD3/HDAC1/SMAD4",4
"R-HSA-1643685","R-HSA-1643685","Disease","15/35","443/2914",7.2950412219668e-05,0.00110177380524358,0.000720498732491853,"MAPK3/ESR1/CDK5/GSK3A/MAPK1/AKT2/STAT3/SMAD2/SMAD3/HDAC1/AKT3/SMAD4/AKT1/STAT1/AXIN1",15
"R-HSA-445144","R-HSA-445144","Signal transduction by L1","4/35","20/2914",7.37908553165448e-05,0.00110177380524358,0.000720498732491853,"MAPK3/MAPK1/CSNK2A1/PAK1",4
"R-HSA-9009391","R-HSA-9009391","Extra-nuclear estrogen signaling","6/35","63/2914",7.97934526317612e-05,0.0011154496594185,0.000729441979782607,"MAPK3/ESR1/MAPK1/AKT2/AKT3/AKT1",6
"R-HSA-69202","R-HSA-69202","Cyclin E associated events during G1/S transition ","5/35","39/2914",7.98589825449731e-05,0.0011154496594185,0.000729441979782607,"CDK2/AKT2/AKT3/AKT1/E2F4",5
"R-HSA-397795","R-HSA-397795","G-protein beta:gamma signalling","4/35","21/2914",9.03775644576542e-05,0.00118511281828947,0.000774997807511526,"AKT2/PAK1/AKT3/AKT1",4
"R-HSA-69656","R-HSA-69656","Cyclin A:Cdk2-associated events at S phase entry","5/35","40/2914",9.04821037772475e-05,0.00118511281828947,0.000774997807511526,"CDK2/AKT2/AKT3/AKT1/E2F4",5
"R-HSA-1640170","R-HSA-1640170","Cell Cycle","11/35","249/2914",9.30573575562167e-05,0.00118511281828947,0.000774997807511526,"MAPK3/MAPK1/CSNK2A1/CDK2/AKT2/CSNK1D/HDAC1/AKT3/AKT1/RBL1/E2F4",11
"R-HSA-2559583","R-HSA-2559583","Cellular Senescence","7/35","99/2914",0.000129993726043397,0.00157839439931657,0.00103218206737853,"MAPK3/CEBPB/MAPK1/CDK2/STAT3/SP1/MAPKAPK2",7
"R-HSA-1257604","R-HSA-1257604","PIP3 activates AKT signaling","9/35","172/2914",0.000131229095555188,0.00157839439931657,0.00103218206737853,"MAPK3/ESR1/GSK3A/MAPK1/CSNK2A1/AKT2/HDAC1/AKT3/AKT1",9
"R-HSA-5674400","R-HSA-5674400","Constitutive Signaling by AKT1 E17K in Cancer","4/35","24/2914",0.000156398090693995,0.00178211508606579,0.00116540405530982,"GSK3A/AKT2/AKT3/AKT1",4
"R-HSA-982772","R-HSA-982772","Growth hormone receptor signaling","4/35","24/2914",0.000156398090693995,0.00178211508606579,0.00116540405530982,"MAPK3/MAPK1/STAT3/STAT1",4
"R-HSA-2559582","R-HSA-2559582","Senescence-Associated Secretory Phenotype (SASP)","5/35","45/2914",0.000160897995000916,0.00178638030347171,0.00116819327004714,"MAPK3/CEBPB/MAPK1/CDK2/STAT3",5
"R-HSA-1362300","R-HSA-1362300","Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1","3/35","10/2914",0.000179917841739733,0.00185891987190506,0.00121563010949911,"HDAC1/RBL1/E2F4",3
"R-HSA-6804759","R-HSA-6804759","Regulation of TP53 Activity through Association with Co-factors","3/35","10/2914",0.000179917841739733,0.00185891987190506,0.00121563010949911,"AKT2/AKT3/AKT1",3
"R-HSA-5218920","R-HSA-5218920","VEGFR2 mediated vascular permeability","4/35","25/2914",0.000184604051944382,0.00185891987190506,0.00121563010949911,"AKT2/PAK1/AKT3/AKT1",4
"R-HSA-8948751","R-HSA-8948751","Regulation of PTEN stability and activity","4/35","25/2914",0.000184604051944382,0.00185891987190506,0.00121563010949911,"CSNK2A1/AKT2/AKT3/AKT1",4
"R-HSA-9018519","R-HSA-9018519","Estrogen-dependent gene expression","5/35","49/2914",0.000242591087719896,0.00216810607893538,0.00141782067639143,"MYB/ESR1/SP1/HDAC1/AXIN1",5
"R-HSA-1358803","R-HSA-1358803","Downregulation of ERBB2:ERBB3 signaling","3/35","11/2914",0.000245351496230562,0.00216810607893538,0.00141782067639143,"AKT2/AKT3/AKT1",3
"R-HSA-1362277","R-HSA-1362277","Transcription of E2F targets under negative control by DREAM complex","3/35","11/2914",0.000245351496230562,0.00216810607893538,0.00141782067639143,"HDAC1/RBL1/E2F4",3
"R-HSA-210745","R-HSA-210745","Regulation of gene expression in beta cells","3/35","11/2914",0.000245351496230562,0.00216810607893538,0.00141782067639143,"AKT2/AKT3/AKT1",3
"R-HSA-452723","R-HSA-452723","Transcriptional regulation of pluripotent stem cells","3/35","11/2914",0.000245351496230562,0.00216810607893538,0.00141782067639143,"STAT3/SMAD2/SMAD4",3
"R-HSA-9614399","R-HSA-9614399","Regulation of localization of FOXO transcription factors","3/35","11/2914",0.000245351496230562,0.00216810607893538,0.00141782067639143,"AKT2/AKT3/AKT1",3
"R-HSA-9616222","R-HSA-9616222","Transcriptional regulation of granulopoiesis","4/35","27/2914",0.000251771756643038,0.00218034341252871,0.00142582321130478,"MYB/CEBPB/CDK2/STAT3",4
"R-HSA-1502540","R-HSA-1502540","Signaling by Activin","3/35","12/2914",0.000324444397921335,0.0027365565436615,0.00178955563448388,"SMAD2/SMAD3/SMAD4",3
"R-HSA-6804757","R-HSA-6804757","Regulation of TP53 Degradation","4/35","29/2914",0.000334959576937782,0.0027365565436615,0.00178955563448388,"CDK2/AKT2/AKT3/AKT1",4
"R-HSA-6806003","R-HSA-6806003","Regulation of TP53 Expression and Degradation","4/35","29/2914",0.000334959576937782,0.0027365565436615,0.00178955563448388,"CDK2/AKT2/AKT3/AKT1",4
"R-HSA-8876198","R-HSA-8876198","RAB GEFs exchange GTP for GDP on RABs","3/35","13/2914",0.000418309302615694,0.00331385380036852,0.00216707590202779,"AKT2/AKT3/AKT1",3
"R-HSA-9006925","R-HSA-9006925","Intracellular signaling by second messengers","9/35","201/2914",0.000431177312610793,0.00331385380036852,0.00216707590202779,"MAPK3/ESR1/GSK3A/MAPK1/CSNK2A1/AKT2/HDAC1/AKT3/AKT1",9
"R-HSA-9006934","R-HSA-9006934","Signaling by Receptor Tyrosine Kinases","12/35","347/2914",0.000435139705758501,0.00331385380036852,0.00216707590202779,"MAPK3/ESR1/CDK5/MAPK1/AKT2/PAK1/STAT3/YAP1/MAPKAPK2/AKT3/AKT1/STAT1",12
"R-HSA-389356","R-HSA-389356","CD28 co-stimulation","4/35","31/2914",0.000436234795891468,0.00331385380036852,0.00216707590202779,"AKT2/PAK1/AKT3/AKT1",4
"R-HSA-8878171","R-HSA-8878171","Transcriptional regulation by RUNX1","6/35","86/2914",0.000452558567199856,0.00337858378616444,0.00220940570919712,"MYB/ESR1/CSNK2A1/YAP1/HDAC1/AXIN1",6
"R-HSA-9617828","R-HSA-9617828","FOXO-mediated transcription of cell cycle genes","3/35","14/2914",0.00052801690658879,0.00387510712801603,0.00253410433313799,"SMAD2/SMAD3/SMAD4",3
"R-HSA-111447","R-HSA-111447","Activation of BAD and translocation to mitochondria ","3/35","15/2914",0.000654596783448783,0.00457161947150521,0.00298958463069139,"AKT2/AKT3/AKT1",3
"R-HSA-1181150","R-HSA-1181150","Signaling by NODAL","3/35","15/2914",0.000654596783448783,0.00457161947150521,0.00298958463069139,"SMAD2/SMAD3/SMAD4",3
"R-HSA-69205","R-HSA-69205","G1/S-Specific Transcription","3/35","15/2914",0.000654596783448783,0.00457161947150521,0.00298958463069139,"HDAC1/RBL1/E2F4",3
"R-HSA-392451","R-HSA-392451","G beta:gamma signalling through PI3Kgamma","3/35","16/2914",0.000799038304513446,0.00549180295006861,0.00359133339873211,"AKT2/AKT3/AKT1",3
"R-HSA-199418","R-HSA-199418","Negative regulation of the PI3K/AKT network","6/35","99/2914",0.000963744088784384,0.00652033110068185,0.00426393355070722,"MAPK3/ESR1/MAPK1/AKT2/AKT3/AKT1",6
"R-HSA-109581","R-HSA-109581","Apoptosis","6/35","101/2914",0.00107128453865779,0.00713640315752036,0.00466681037893029,"MAPK3/MAPK1/AKT2/STAT3/AKT3/AKT1",6
"R-HSA-5357801","R-HSA-5357801","Programmed Cell Death","6/35","103/2914",0.00118787656353479,0.00779319018197824,0.00509631252935978,"MAPK3/MAPK1/AKT2/STAT3/AKT3/AKT1",6
"R-HSA-389513","R-HSA-389513","CTLA4 inhibitory signaling","3/35","19/2914",0.00134884228707327,0.00871714492989146,0.00570052749760739,"AKT2/AKT3/AKT1",3
"R-HSA-69242","R-HSA-69242","S Phase","5/35","71/2914",0.0013695096095988,0.00872055383759235,0.00570275673346868,"CDK2/AKT2/AKT3/AKT1/E2F4",5
"R-HSA-389357","R-HSA-389357","CD28 dependent PI3K/Akt signaling","3/35","21/2914",0.0018210969964003,0.0114280434701642,0.00747330422626517,"AKT2/AKT3/AKT1",3
"R-HSA-112409","R-HSA-112409","RAF-independent MAPK1/3 activation","3/35","23/2914",0.0023853301066914,0.014547154030949,0.0095130288910302,"MAPK3/MAPK1/DUSP2",3
"R-HSA-2559585","R-HSA-2559585","Oncogene Induced Senescence","3/35","23/2914",0.0023853301066914,0.014547154030949,0.0095130288910302,"MAPK3/MAPK1/SP1",3
"R-HSA-186712","R-HSA-186712","Regulation of beta-cell development","3/35","24/2914",0.0027037489661196,0.0158205851666187,0.0103457819613965,"AKT2/AKT3/AKT1",3
"R-HSA-198725","R-HSA-198725","Nuclear Events (kinase and transcription factor activation)","3/35","24/2914",0.0027037489661196,0.0158205851666187,0.0103457819613965,"MAPK3/MAPK1/MAPKAPK2",3
"R-HSA-8863795","R-HSA-8863795","Downregulation of ERBB2 signaling","3/35","24/2914",0.0027037489661196,0.0158205851666187,0.0103457819613965,"AKT2/AKT3/AKT1",3
"R-HSA-9007101","R-HSA-9007101","Rab regulation of trafficking","3/35","25/2914",0.00304726872714349,0.0174166118312871,0.0113894945487206,"AKT2/AKT3/AKT1",3
"R-HSA-4420097","R-HSA-4420097","VEGFA-VEGFR2 Pathway","5/35","85/2914",0.00305695727292799,0.0174166118312871,0.0113894945487206,"AKT2/PAK1/MAPKAPK2/AKT3/AKT1",5
"R-HSA-373760","R-HSA-373760","L1CAM interactions","4/35","53/2914",0.0033651865062518,0.0186810994513722,0.0122163990577832,"MAPK3/MAPK1/CSNK2A1/PAK1",4
"R-HSA-388841","R-HSA-388841","Costimulation by the CD28 family","4/35","53/2914",0.0033651865062518,0.0186810994513722,0.0122163990577832,"AKT2/PAK1/AKT3/AKT1",4
"R-HSA-166520","R-HSA-166520","Signaling by NTRKs","5/35","89/2914",0.00373686142988577,0.0204817847992473,0.0133939470305033,"MAPK3/CDK5/MAPK1/STAT3/MAPKAPK2",5
"R-HSA-165159","R-HSA-165159","mTOR signalling","3/35","27/2914",0.00381211792571346,0.0206330882729241,0.01349289107917,"AKT2/STK11/AKT1",3
"R-HSA-6804756","R-HSA-6804756","Regulation of TP53 Activity through Phosphorylation","4/35","56/2914",0.00411447131415991,0.021994642951003,0.0143832720404031,"CDK5/CSNK2A1/CDK2/STK11",4
"R-HSA-2173789","R-HSA-2173789","TGF-beta receptor signaling activates SMADs","3/35","28/2914",0.00423462384795922,0.0223608795873944,0.01462277041208,"SMAD2/SMAD3/SMAD4",3
"R-HSA-194138","R-HSA-194138","Signaling by VEGF","5/35","92/2914",0.00431400125091792,0.0225055727909332,0.0147173917120725,"AKT2/PAK1/MAPKAPK2/AKT3/AKT1",5
"R-HSA-597592","R-HSA-597592","Post-translational protein modification","11/35","393/2914",0.00467202762254285,0.0238638276780008,0.0156056147936847,"ESR1/SMAD2/SMAD3/FBXO22/PIAS1/CSNK1D/HDAC1/PEX14/PARP1/SMAD4/AXIN1",11
"R-HSA-114452","R-HSA-114452","Activation of BH3-only proteins","3/35","29/2914",0.00468458511000016,0.0238638276780008,0.0156056147936847,"AKT2/AKT3/AKT1",3
"R-HSA-2871796","R-HSA-2871796","FCERI mediated MAPK activation","3/35","30/2914",0.00516251623443024,0.0254019264716852,0.0166114457782504,"MAPK3/MAPK1/PAK1",3
"R-HSA-450282","R-HSA-450282","MAPK targets/ Nuclear events mediated by MAP kinases","3/35","30/2914",0.00516251623443024,0.0254019264716852,0.0166114457782504,"MAPK3/MAPK1/MAPKAPK2",3
"R-HSA-6791312","R-HSA-6791312","TP53 Regulates Transcription of Cell Cycle Genes","3/35","30/2914",0.00516251623443024,0.0254019264716852,0.0166114457782504,"CDK2/RBL1/E2F4",3
"R-HSA-2219528","R-HSA-2219528","PI3K/AKT Signaling in Cancer","5/35","97/2914",0.0054143313683361,0.0262366162876718,0.0171572864504284,"ESR1/GSK3A/AKT2/AKT3/AKT1",5
"R-HSA-3769402","R-HSA-3769402","Deactivation of the beta-catenin transactivating complex","3/35","31/2914",0.00566890353141653,0.0262366162876718,0.0171572864504284,"AKT2/HDAC1/AKT1",3
"R-HSA-2262752","R-HSA-2262752","Cellular responses to stress","7/35","187/2914",0.00578287998789886,0.0262366162876718,0.0171572864504284,"MAPK3/CEBPB/MAPK1/CDK2/STAT3/SP1/MAPKAPK2",7
"R-HSA-983231","R-HSA-983231","Factors involved in megakaryocyte development and platelet production","4/35","62/2914",0.00593798934334313,0.0262366162876718,0.0171572864504284,"MYB/CDK5/CDK2/HDAC1",4
"R-HSA-111458","R-HSA-111458","Formation of apoptosome","2/35","10/2914",0.00593807943693264,0.0262366162876718,0.0171572864504284,"MAPK3/MAPK1",2
"R-HSA-450341","R-HSA-450341","Activation of the AP-1 family of transcription factors","2/35","10/2914",0.00593807943693264,0.0262366162876718,0.0171572864504284,"MAPK3/MAPK1",2
"R-HSA-74749","R-HSA-74749","Signal attenuation","2/35","10/2914",0.00593807943693264,0.0262366162876718,0.0171572864504284,"MAPK3/MAPK1",2
"R-HSA-9020956","R-HSA-9020956","Interleukin-27 signaling","2/35","10/2914",0.00593807943693264,0.0262366162876718,0.0171572864504284,"STAT3/STAT1",2
"R-HSA-9020958","R-HSA-9020958","Interleukin-21 signaling","2/35","10/2914",0.00593807943693264,0.0262366162876718,0.0171572864504284,"STAT3/STAT1",2
"R-HSA-9627069","R-HSA-9627069","Regulation of the apoptosome activity","2/35","10/2914",0.00593807943693264,0.0262366162876718,0.0171572864504284,"MAPK3/MAPK1",2
"R-HSA-8953897","R-HSA-8953897","Cellular responses to external stimuli","7/35","189/2914",0.0061301583711053,0.0265982287706447,0.0173937608831978,"MAPK3/CEBPB/MAPK1/CDK2/STAT3/SP1/MAPKAPK2",7
"R-HSA-3371453","R-HSA-3371453","Regulation of HSF1-mediated heat shock response","3/35","32/2914",0.00620420578714807,0.0265982287706447,0.0173937608831978,"MAPK3/MAPK1/MAPKAPK2",3
"R-HSA-8943724","R-HSA-8943724","Regulation of PTEN gene transcription","3/35","32/2914",0.00620420578714807,0.0265982287706447,0.0173937608831978,"MAPK3/MAPK1/HDAC1",3
"R-HSA-187687","R-HSA-187687","Signalling to ERKs","3/35","33/2914",0.00676885493961992,0.0287344528319159,0.0187907324949201,"MAPK3/MAPK1/MAPKAPK2",3
"R-HSA-1059683","R-HSA-1059683","Interleukin-6 signaling","2/35","11/2914",0.00720313009042199,0.0299899550880069,0.0196117610761489,"STAT3/STAT1",2
"R-HSA-8984722","R-HSA-8984722","Interleukin-35 Signalling","2/35","11/2914",0.00720313009042199,0.0299899550880069,0.0196117610761489,"STAT3/STAT1",2
"R-HSA-5675221","R-HSA-5675221","Negative regulation of MAPK pathway","3/35","34/2914",0.00736325674195048,0.0303646682787101,0.0198568026424529,"MAPK3/MAPK1/DUSP2",3
"R-HSA-5628897","R-HSA-5628897","TP53 Regulates Metabolic Genes","3/35","35/2914",0.00798779141342696,0.0326293743586215,0.0213377943417265,"AKT2/AKT3/AKT1",3
"R-HSA-201681","R-HSA-201681","TCF dependent signaling in response to WNT","5/35","108/2914",0.00851570417471669,0.0334653109020115,0.0218844503042205,"CSNK2A1/AKT2/HDAC1/AKT1/AXIN1",5
"R-HSA-111461","R-HSA-111461","Cytochrome c-mediated apoptotic response","2/35","12/2914",0.00857886722892212,0.0334653109020115,0.0218844503042205,"MAPK3/MAPK1",2
"R-HSA-170968","R-HSA-170968","Frs2-mediated activation","2/35","12/2914",0.00857886722892212,0.0334653109020115,0.0218844503042205,"MAPK3/MAPK1",2
"R-HSA-1839117","R-HSA-1839117","Signaling by cytosolic FGFR1 fusion mutants","2/35","12/2914",0.00857886722892212,0.0334653109020115,0.0218844503042205,"STAT3/STAT1",2
"R-HSA-202670","R-HSA-202670","ERKs are inactivated","2/35","12/2914",0.00857886722892212,0.0334653109020115,0.0218844503042205,"MAPK3/MAPK1",2
"R-HSA-187037","R-HSA-187037","Signaling by NTRK1 (TRKA)","4/35","70/2914",0.00911804719613492,0.0352510217493431,0.0230522057872208,"MAPK3/MAPK1/STAT3/MAPKAPK2",4
"R-HSA-169893","R-HSA-169893","Prolonged ERK activation events","2/35","13/2914",0.0100626050337051,0.0385584776955249,0.0252150978487813,"MAPK3/MAPK1",2
"R-HSA-1295596","R-HSA-1295596","Spry regulation of FGF signaling","2/35","14/2914",0.0116517030548912,0.0438711949805902,0.0286893191923636,"MAPK3/MAPK1",2
"R-HSA-877312","R-HSA-877312","Regulation of IFNG signaling","2/35","14/2914",0.0116517030548912,0.0438711949805902,0.0286893191923636,"PIAS1/STAT1",2
"R-HSA-6804114","R-HSA-6804114","TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest","2/35","15/2914",0.01334356555819,0.0493825973221903,0.0322934695020523,"RBL1/E2F4",2
"R-HSA-9008059","R-HSA-9008059","Interleukin-37 signaling","2/35","15/2914",0.01334356555819,0.0493825973221903,0.0322934695020523,"STAT3/SMAD3",2
"R-HSA-2029482","R-HSA-2029482","Regulation of actin dynamics for phagocytic cup formation","3/35","43/2914",0.0141065474464151,0.0517638563076079,0.0338506803129854,"MAPK3/MAPK1/PAK1",3
"R-HSA-5689880","R-HSA-5689880","Ub-specific processing proteases","4/35","80/2914",0.014447503784005,0.0525694885586064,0.034377518955306,"SMAD2/SMAD3/SMAD4/AXIN1",4
"R-HSA-5688426","R-HSA-5688426","Deubiquitination","5/35","124/2914",0.014980145869083,0.0528526814605021,0.0345627113476968,"ESR1/SMAD2/SMAD3/SMAD4/AXIN1",5
"R-HSA-1227986","R-HSA-1227986","Signaling by ERBB2","3/35","44/2914",0.0150154817682019,0.0528526814605021,0.0345627113476968,"AKT2/AKT3/AKT1",3
"R-HSA-2559580","R-HSA-2559580","Oxidative Stress Induced Senescence","3/35","44/2914",0.0150154817682019,0.0528526814605021,0.0345627113476968,"MAPK3/MAPK1/MAPKAPK2",3
"R-HSA-111471","R-HSA-111471","Apoptotic factor-mediated response","2/35","16/2914",0.0151356408801438,0.0528526814605021,0.0345627113476968,"MAPK3/MAPK1",2
"R-HSA-5668599","R-HSA-5668599","RHO GTPases Activate NADPH Oxidases","2/35","16/2914",0.0151356408801438,0.0528526814605021,0.0345627113476968,"MAPK3/MAPK1",2
"R-HSA-877300","R-HSA-877300","Interferon gamma signaling","3/35","47/2914",0.0179388153018851,0.0611614726434349,0.0399961982279907,"PIAS1/CIITA/STAT1",3
"R-HSA-8848021","R-HSA-8848021","Signaling by PTK6","3/35","47/2914",0.0179388153018851,0.0611614726434349,0.0399961982279907,"CDK2/STAT3/AKT1",3
"R-HSA-9006927","R-HSA-9006927","Signaling by Non-Receptor Tyrosine Kinases","3/35","47/2914",0.0179388153018851,0.0611614726434349,0.0399961982279907,"CDK2/STAT3/AKT1",3
"R-HSA-881907","R-HSA-881907","Gastrin-CREB signalling pathway via PKC and MAPK","2/35","18/2914",0.0190104398704978,0.0643087536244184,0.0420543447793085,"MAPK3/MAPK1",2
"R-HSA-3371556","R-HSA-3371556","Cellular response to heat stress","3/35","49/2914",0.0200526401347948,0.0673084742509003,0.0440159950735194,"MAPK3/MAPK1/MAPKAPK2",3
"R-HSA-6811558","R-HSA-6811558","PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling","4/35","92/2914",0.0230554368599458,0.0758470888177044,0.0495997736525161,"MAPK3/ESR1/MAPK1/AKT1",4
"R-HSA-73854","R-HSA-73854","RNA Polymerase I Promoter Clearance","2/35","20/2914",0.0232565441599844,0.0758470888177044,0.0495997736525161,"MAPK3/HDAC1",2
"R-HSA-73864","R-HSA-73864","RNA Polymerase I Transcription","2/35","20/2914",0.0232565441599844,0.0758470888177044,0.0495997736525161,"MAPK3/HDAC1",2
"R-HSA-74751","R-HSA-74751","Insulin receptor signalling cascade","3/35","52/2914",0.0234723092415067,0.0758470888177044,0.0495997736525161,"MAPK3/MAPK1/AKT2",3
"R-HSA-74752","R-HSA-74752","Signaling by Insulin receptor","3/35","52/2914",0.0234723092415067,0.0758470888177044,0.0495997736525161,"MAPK3/MAPK1/AKT2",3
"R-HSA-8878159","R-HSA-8878159","Transcriptional regulation by RUNX3","3/35","53/2914",0.024678736605622,0.0791547625943283,0.051762808163059,"SMAD3/YAP1/SMAD4",3
"R-HSA-198753","R-HSA-198753","ERK/MAPK targets","2/35","21/2914",0.025512907019309,0.0812285936717705,0.0531189782367966,"MAPK3/MAPK1",2
"R-HSA-913531","R-HSA-913531","Interferon Signaling","4/35","97/2914",0.0274047030160352,0.0866148642769581,0.0566412993569994,"MAPK3/PIAS1/CIITA/STAT1",4
"R-HSA-2173788","R-HSA-2173788","Downregulation of TGF-beta receptor signaling","2/35","22/2914",0.0278550631432467,0.0867715276332794,0.0567437484705291,"SMAD2/SMAD3",2
"R-HSA-442742","R-HSA-442742","CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling","2/35","22/2914",0.0278550631432467,0.0867715276332794,0.0567437484705291,"MAPK3/MAPK1",2
"R-HSA-4551638","R-HSA-4551638","SUMOylation of chromatin organization proteins","2/35","23/2914",0.030280752003871,0.0929898270757174,0.0608101701309541,"PIAS1/HDAC1",2
"R-HSA-6783589","R-HSA-6783589","Interleukin-6 family signaling","2/35","23/2914",0.030280752003871,0.0929898270757174,0.0608101701309541,"STAT3/STAT1",2
"R-HSA-1839124","R-HSA-1839124","FGFR1 mutant receptor activation","2/35","24/2914",0.0327877522800303,0.0992803967640078,0.0649238525088564,"STAT3/STAT1",2
"R-HSA-8854691","R-HSA-8854691","Interleukin-20 family signaling","2/35","24/2914",0.0327877522800303,0.0992803967640078,0.0649238525088564,"STAT3/STAT1",2
"R-HSA-450294","R-HSA-450294","MAP kinase activation","3/35","60/2914",0.0340541904173964,0.102361710192896,0.066938859953541,"MAPK3/MAPK1/MAPKAPK2",3
"R-HSA-157118","R-HSA-157118","Signaling by NOTCH","4/35","104/2914",0.0342781708498151,0.102361710192896,0.066938859953541,"SMAD3/HDAC1/AKT1/STAT1",4
"R-HSA-68886","R-HSA-68886","M Phase","4/35","105/2914",0.0353359009719889,0.103492504028678,0.0676783361704498,"MAPK3/MAPK1/CSNK2A1/CSNK1D",4
"R-HSA-456926","R-HSA-456926","Thrombin signalling through proteinase activated receptors (PARs)","2/35","25/2914",0.0353738812846291,0.103492504028678,0.0676783361704498,"MAPK3/MAPK1",2
"R-HSA-5663213","R-HSA-5663213","RHO GTPases Activate WASPs and WAVEs","2/35","25/2914",0.0353738812846291,0.103492504028678,0.0676783361704498,"MAPK3/MAPK1",2
"R-HSA-2029480","R-HSA-2029480","Fcgamma receptor (FCGR) dependent phagocytosis","3/35","62/2914",0.0370303036533544,0.107611553569815,0.0703719652614082,"MAPK3/MAPK1/PAK1",3
"R-HSA-3108232","R-HSA-3108232","SUMO E3 ligases SUMOylate target proteins","4/35","107/2914",0.0375086773875039,0.108275048725261,0.0708058541560601,"ESR1/PIAS1/HDAC1/PARP1",4
"R-HSA-1445148","R-HSA-1445148","Translocation of SLC2A4 (GLUT4) to the plasma membrane","2/35","26/2914",0.0380369943994376,0.108355385361556,0.0708583898438276,"AKT2/AKT1",2
"R-HSA-8939902","R-HSA-8939902","Regulation of RUNX2 expression and activity","2/35","26/2914",0.0380369943994376,0.108355385361556,0.0708583898438276,"ESR1/STAT1",2
"R-HSA-2990846","R-HSA-2990846","SUMOylation","4/35","109/2914",0.0397580950103315,0.112455849019148,0.0735398648016309,"ESR1/PIAS1/HDAC1/PARP1",4
"R-HSA-448424","R-HSA-448424","Interleukin-17 signaling","3/35","64/2914",0.0401372288851415,0.112455849019148,0.0735398648016309,"MAPK3/MAPK1/MAPKAPK2",3
"R-HSA-1251985","R-HSA-1251985","Nuclear signaling by ERBB4","2/35","27/2914",0.0407749845173355,0.112455849019148,0.0735398648016309,"ESR1/YAP1",2
"R-HSA-5654732","R-HSA-5654732","Negative regulation of FGFR3 signaling","2/35","27/2914",0.0407749845173355,0.112455849019148,0.0735398648016309,"MAPK3/MAPK1",2
"R-HSA-8939236","R-HSA-8939236","RUNX1 regulates transcription of genes involved in differentiation of HSCs","2/35","27/2914",0.0407749845173355,0.112455849019148,0.0735398648016309,"MYB/YAP1",2
"R-HSA-4090294","R-HSA-4090294","SUMOylation of intracellular receptors","2/35","28/2914",0.0435857814919029,0.118695870352163,0.077620491369228,"ESR1/PIAS1",2
"R-HSA-5654733","R-HSA-5654733","Negative regulation of FGFR4 signaling","2/35","28/2914",0.0435857814919029,0.118695870352163,0.077620491369228,"MAPK3/MAPK1",2
"R-HSA-186763","R-HSA-186763","Downstream signal transduction","2/35","29/2914",0.0464673515942661,0.124971200250417,0.0817242077728511,"STAT3/STAT1",2
"R-HSA-381119","R-HSA-381119","Unfolded Protein Response (UPR)","2/35","29/2914",0.0464673515942661,0.124971200250417,0.0817242077728511,"CEBPB/GSK3A",2
"R-HSA-390466","R-HSA-390466","Chaperonin-mediated protein folding","2/35","30/2914",0.0494176969771115,0.130474773116398,0.0853232380413543,"CSNK2A1/STAT3",2
"R-HSA-5654726","R-HSA-5654726","Negative regulation of FGFR1 signaling","2/35","30/2914",0.0494176969771115,0.130474773116398,0.0853232380413543,"MAPK3/MAPK1",2
"R-HSA-5696395","R-HSA-5696395","Formation of Incision Complex in GG-NER","2/35","30/2914",0.0494176969771115,0.130474773116398,0.0853232380413543,"PIAS1/PARP1",2
"R-HSA-195721","R-HSA-195721","Signaling by WNT","5/35","172/2914",0.0520340704385944,0.135144596893588,0.088377042820895,"CSNK2A1/AKT2/HDAC1/AKT1/AXIN1",5
"R-HSA-391251","R-HSA-391251","Protein folding","2/35","31/2914",0.0524348551457801,0.135144596893588,0.088377042820895,"CSNK2A1/STAT3",2
"R-HSA-450531","R-HSA-450531","Regulation of mRNA stability by proteins that bind AU-rich elements","2/35","31/2914",0.0524348551457801,0.135144596893588,0.088377042820895,"MAPKAPK2/AKT1",2
"R-HSA-5655302","R-HSA-5655302","Signaling by FGFR1 in disease","2/35","31/2914",0.0524348551457801,0.135144596893588,0.088377042820895,"STAT3/STAT1",2
"R-HSA-375165","R-HSA-375165","NCAM signaling for neurite out-growth","2/35","32/2914",0.0555168984363555,0.139760564086872,0.0913956283927762,"MAPK3/MAPK1",2
"R-HSA-447115","R-HSA-447115","Interleukin-12 family signaling","2/35","32/2914",0.0555168984363555,0.139760564086872,0.0913956283927762,"STAT3/STAT1",2
"R-HSA-5654727","R-HSA-5654727","Negative regulation of FGFR2 signaling","2/35","32/2914",0.0555168984363555,0.139760564086872,0.0913956283927762,"MAPK3/MAPK1",2
"R-HSA-6802948","R-HSA-6802948","Signaling by high-kinase activity BRAF mutants","2/35","32/2914",0.0555168984363555,0.139760564086872,0.0913956283927762,"MAPK3/MAPK1",2
"R-HSA-68875","R-HSA-68875","Mitotic Prophase","2/35","33/2914",0.058661933500661,0.146824376912059,0.0960149687354902,"MAPK3/MAPK1",2
"R-HSA-109582","R-HSA-109582","Hemostasis","7/35","298/2914",0.0598039155316276,0.148822387501119,0.0973215564307793,"MYB/MAPK3/CDK5/MAPK1/CDK2/HDAC1/AKT1",7
"R-HSA-1169408","R-HSA-1169408","ISG15 antiviral mechanism","2/35","34/2914",0.0618681007980805,0.152209588895278,0.0995365975758592,"MAPK3/STAT1",2
"R-HSA-5674135","R-HSA-5674135","MAP2K and MAPK activation","2/35","34/2914",0.0618681007980805,0.152209588895278,0.0995365975758592,"MAPK3/MAPK1",2
"R-HSA-1169410","R-HSA-1169410","Antiviral mechanism by IFN-stimulated genes","2/35","35/2914",0.0651335740941201,0.15742075941449,0.102944412987718,"MAPK3/STAT1",2
"R-HSA-168142","R-HSA-168142","Toll Like Receptor 10 (TLR10) Cascade","3/35","78/2914",0.0654405004494414,0.15742075941449,0.102944412987718,"MAPK3/MAPK1/MAPKAPK2",3
"R-HSA-168176","R-HSA-168176","Toll Like Receptor 5 (TLR5) Cascade","3/35","78/2914",0.0654405004494414,0.15742075941449,0.102944412987718,"MAPK3/MAPK1/MAPKAPK2",3
"R-HSA-975871","R-HSA-975871","MyD88 cascade initiated on plasma membrane","3/35","78/2914",0.0654405004494414,0.15742075941449,0.102944412987718,"MAPK3/MAPK1/MAPKAPK2",3
"R-HSA-195253","R-HSA-195253","Degradation of beta-catenin by the destruction complex","2/35","37/2914",0.0718352973125952,0.170904855694251,0.111762261290273,"HDAC1/AXIN1",2
"R-HSA-5654741","R-HSA-5654741","Signaling by FGFR3","2/35","37/2914",0.0718352973125952,0.170904855694251,0.111762261290273,"MAPK3/MAPK1",2
"R-HSA-3108214","R-HSA-3108214","SUMOylation of DNA damage response and repair proteins","2/35","38/2914",0.0752680568764405,0.17616793852702,0.115204024465221,"PIAS1/PARP1",2
"R-HSA-373755","R-HSA-373755","Semaphorin interactions","2/35","38/2914",0.0752680568764405,0.17616793852702,0.115204024465221,"CDK5/PAK1",2
"R-HSA-5654743","R-HSA-5654743","Signaling by FGFR4","2/35","38/2914",0.0752680568764405,0.17616793852702,0.115204024465221,"MAPK3/MAPK1",2
"R-HSA-975138","R-HSA-975138","TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation","3/35","83/2914",0.0759148610427055,0.176726531352105,0.115569313075766,"MAPK3/MAPK1/MAPKAPK2",3
"R-HSA-168181","R-HSA-168181","Toll Like Receptor 7/8 (TLR7/8) Cascade","3/35","84/2914",0.0780954971624728,0.179868884422078,0.117624237047621,"MAPK3/MAPK1/MAPKAPK2",3
"R-HSA-975155","R-HSA-975155","MyD88 dependent cascade initiated on endosome","3/35","84/2914",0.0780954971624728,0.179868884422078,0.117624237047621,"MAPK3/MAPK1/MAPKAPK2",3
"R-HSA-69231","R-HSA-69231","Cyclin D associated events in G1","2/35","40/2914",0.0822888819822111,0.184226453914226,0.120473844908051,"RBL1/E2F4",2
"R-HSA-69236","R-HSA-69236","G1 Phase","2/35","40/2914",0.0822888819822111,0.184226453914226,0.120473844908051,"RBL1/E2F4",2
"R-HSA-9013694","R-HSA-9013694","Signaling by NOTCH4","2/35","40/2914",0.0822888819822111,0.184226453914226,0.120473844908051,"SMAD3/AKT1",2
"R-HSA-166058","R-HSA-166058","MyD88:MAL(TIRAP) cascade initiated on plasma membrane","3/35","86/2914",0.0825402587975976,0.184226453914226,0.120473844908051,"MAPK3/MAPK1/MAPKAPK2",3
"R-HSA-168138","R-HSA-168138","Toll Like Receptor 9 (TLR9) Cascade","3/35","86/2914",0.0825402587975976,0.184226453914226,0.120473844908051,"MAPK3/MAPK1/MAPKAPK2",3
"R-HSA-168188","R-HSA-168188","Toll Like Receptor TLR6:TLR2 Cascade","3/35","86/2914",0.0825402587975976,0.184226453914226,0.120473844908051,"MAPK3/MAPK1/MAPKAPK2",3
"R-HSA-168164","R-HSA-168164","Toll Like Receptor 3 (TLR3) Cascade","3/35","87/2914",0.0848037936668788,0.184991481782111,0.120974130544276,"MAPK3/MAPK1/MAPKAPK2",3
"R-HSA-168179","R-HSA-168179","Toll Like Receptor TLR1:TLR2 Cascade","3/35","87/2914",0.0848037936668788,0.184991481782111,0.120974130544276,"MAPK3/MAPK1/MAPKAPK2",3
"R-HSA-181438","R-HSA-181438","Toll Like Receptor 2 (TLR2) Cascade","3/35","87/2914",0.0848037936668788,0.184991481782111,0.120974130544276,"MAPK3/MAPK1/MAPKAPK2",3
"R-HSA-2454202","R-HSA-2454202","Fc epsilon receptor (FCERI) signaling","3/35","87/2914",0.0848037936668788,0.184991481782111,0.120974130544276,"MAPK3/MAPK1/PAK1",3
"R-HSA-1433557","R-HSA-1433557","Signaling by SCF-KIT","2/35","41/2914",0.0858736439681395,0.184991481782111,0.120974130544276,"STAT3/STAT1",2
"R-HSA-451927","R-HSA-451927","Interleukin-2 family signaling","2/35","41/2914",0.0858736439681395,0.184991481782111,0.120974130544276,"STAT3/STAT1",2
"R-HSA-5654736","R-HSA-5654736","Signaling by FGFR1","2/35","41/2914",0.0858736439681395,0.184991481782111,0.120974130544276,"MAPK3/MAPK1",2
"R-HSA-6802946","R-HSA-6802946","Signaling by moderate kinase activity BRAF mutants","2/35","42/2914",0.0895058201397502,0.189053756685424,0.123630632182761,"MAPK3/MAPK1",2
"R-HSA-6802949","R-HSA-6802949","Signaling by RAS mutants","2/35","42/2914",0.0895058201397502,0.189053756685424,0.123630632182761,"MAPK3/MAPK1",2
"R-HSA-6802955","R-HSA-6802955","Paradoxical activation of RAF signaling by kinase inactive BRAF","2/35","42/2914",0.0895058201397502,0.189053756685424,0.123630632182761,"MAPK3/MAPK1",2
"R-HSA-9649948","R-HSA-9649948","Signaling downstream of RAS mutants","2/35","42/2914",0.0895058201397502,0.189053756685424,0.123630632182761,"MAPK3/MAPK1",2
"R-HSA-199991","R-HSA-199991","Membrane Trafficking","4/35","144/2914",0.0914653785346372,0.191009996156527,0.12490990389232,"AKT2/CSNK1D/AKT3/AKT1",4
"R-HSA-166166","R-HSA-166166","MyD88-independent TLR4 cascade ","3/35","90/2914",0.0917553792160684,0.191009996156527,0.12490990389232,"MAPK3/MAPK1/MAPKAPK2",3
"R-HSA-937061","R-HSA-937061","TRIF(TICAM1)-mediated TLR4 signaling ","3/35","90/2914",0.0917553792160684,0.191009996156527,0.12490990389232,"MAPK3/MAPK1/MAPKAPK2",3
"R-HSA-449147","R-HSA-449147","Signaling by Interleukins","7/35","332/2914",0.0952816782271477,0.197401754413182,0.129089757960729,"MAPK3/MAPK1/STAT3/SMAD3/MAPKAPK2/AKT1/STAT1",7
"R-HSA-1236394","R-HSA-1236394","Signaling by ERBB4","2/35","44/2914",0.0969061359025147,0.199811223075185,0.130665416329707,"ESR1/YAP1",2
"R-HSA-1226099","R-HSA-1226099","Signaling by FGFR in disease","2/35","45/2914",0.100671208194534,0.206590678427645,0.135098802715538,"STAT3/STAT1",2
"R-HSA-6785807","R-HSA-6785807","Interleukin-4 and Interleukin-13 signaling","3/35","94/2914",0.10138810936686,0.207080430923823,0.135419073583343,"STAT3/AKT1/STAT1",3
"R-HSA-5696399","R-HSA-5696399","Global Genome Nucleotide Excision Repair (GG-NER)","2/35","46/2914",0.104477559203022,0.211396182873404,0.138241335098932,"PIAS1/PARP1",2
"R-HSA-6802952","R-HSA-6802952","Signaling by BRAF and RAF fusions","2/35","46/2914",0.104477559203022,0.211396182873404,0.138241335098932,"MAPK3/MAPK1",2
"R-HSA-438064","R-HSA-438064","Post NMDA receptor activation events","2/35","47/2914",0.108323725598628,0.218158945042818,0.142663805072367,"MAPK3/MAPK1",2
"R-HSA-110056","R-HSA-110056","MAPK3 (ERK1) activation","1/35","10/2914",0.113988288193787,0.22640793021977,0.148058182154171,"MAPK3",1
"R-HSA-381038","R-HSA-381038","XBP1(S) activates chaperone genes","1/35","10/2914",0.113988288193787,0.22640793021977,0.148058182154171,"GSK3A",1
"R-HSA-8934903","R-HSA-8934903","Receptor Mediated Mitophagy","1/35","10/2914",0.113988288193787,0.22640793021977,0.148058182154171,"CSNK2A1",1
"R-HSA-186797","R-HSA-186797","Signaling by PDGF","2/35","49/2914",0.116129787641327,0.227530307912646,0.148792154682148,"STAT3/STAT1",2
"R-HSA-442755","R-HSA-442755","Activation of NMDA receptors and postsynaptic events","2/35","49/2914",0.116129787641327,0.227530307912646,0.148792154682148,"MAPK3/MAPK1",2
"R-HSA-6802957","R-HSA-6802957","Oncogenic MAPK signaling","2/35","49/2914",0.116129787641327,0.227530307912646,0.148792154682148,"MAPK3/MAPK1",2
"R-HSA-5654738","R-HSA-5654738","Signaling by FGFR2","2/35","50/2914",0.120086891796919,0.234223532198496,0.153169150750931,"MAPK3/MAPK1",2
"R-HSA-5653656","R-HSA-5653656","Vesicle-mediated transport","4/35","160/2914",0.122473567374145,0.234698809277329,0.153479955501644,"AKT2/CSNK1D/AKT3/AKT1",4
"R-HSA-110373","R-HSA-110373","Resolution of AP sites via the multiple-nucleotide patch replacement pathway","1/35","11/2914",0.124666804004124,0.234698809277329,0.153479955501644,"PARP1",1
"R-HSA-2586552","R-HSA-2586552","Signaling by Leptin","1/35","11/2914",0.124666804004124,0.234698809277329,0.153479955501644,"STAT3",1
"R-HSA-380994","R-HSA-380994","ATF4 activates genes in response to endoplasmic reticulum  stress","1/35","11/2914",0.124666804004124,0.234698809277329,0.153479955501644,"CEBPB",1
"R-HSA-5627117","R-HSA-5627117","RHO GTPases Activate ROCKs","1/35","11/2914",0.124666804004124,0.234698809277329,0.153479955501644,"PAK1",1
"R-HSA-6804116","R-HSA-6804116","TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest","1/35","11/2914",0.124666804004124,0.234698809277329,0.153479955501644,"CDK2",1
"R-HSA-8866910","R-HSA-8866910","TFAP2 (AP-2) family regulates transcription of growth factors and their receptors","1/35","11/2914",0.124666804004124,0.234698809277329,0.153479955501644,"ESR1",1
"R-HSA-8978868","R-HSA-8978868","Fatty acid metabolism","1/35","11/2914",0.124666804004124,0.234698809277329,0.153479955501644,"MAPKAPK2",1
"R-HSA-1483206","R-HSA-1483206","Glycerophospholipid biosynthesis","1/35","12/2914",0.13522025280187,0.240948022482344,0.157566593041815,"CSNK2A1",1
"R-HSA-2032785","R-HSA-2032785","YAP1- and WWTR1 (TAZ)-stimulated gene expression","1/35","12/2914",0.13522025280187,0.240948022482344,0.157566593041815,"YAP1",1
"R-HSA-204005","R-HSA-204005","COPII-mediated vesicle transport","1/35","12/2914",0.13522025280187,0.240948022482344,0.157566593041815,"CSNK1D",1
"R-HSA-381070","R-HSA-381070","IRE1alpha activates chaperones","1/35","12/2914",0.13522025280187,0.240948022482344,0.157566593041815,"GSK3A",1
"R-HSA-389359","R-HSA-389359","CD28 dependent Vav1 pathway","1/35","12/2914",0.13522025280187,0.240948022482344,0.157566593041815,"PAK1",1
"R-HSA-399954","R-HSA-399954","Sema3A PAK dependent Axon repulsion","1/35","12/2914",0.13522025280187,0.240948022482344,0.157566593041815,"PAK1",1
"R-HSA-6791226","R-HSA-6791226","Major pathway of rRNA processing in the nucleolus and cytosol","1/35","12/2914",0.13522025280187,0.240948022482344,0.157566593041815,"CSNK1D",1
"R-HSA-68962","R-HSA-68962","Activation of the pre-replicative complex","1/35","12/2914",0.13522025280187,0.240948022482344,0.157566593041815,"CDK2",1
"R-HSA-72312","R-HSA-72312","rRNA processing","1/35","12/2914",0.13522025280187,0.240948022482344,0.157566593041815,"CSNK1D",1
"R-HSA-8868773","R-HSA-8868773","rRNA processing in the nucleus and cytosol","1/35","12/2914",0.13522025280187,0.240948022482344,0.157566593041815,"CSNK1D",1
"R-HSA-9005891","R-HSA-9005891","Loss of function of MECP2 in Rett syndrome","1/35","12/2914",0.13522025280187,0.240948022482344,0.157566593041815,"HDAC1",1
"R-HSA-9005895","R-HSA-9005895","Pervasive developmental disorders","1/35","12/2914",0.13522025280187,0.240948022482344,0.157566593041815,"HDAC1",1
"R-HSA-9022699","R-HSA-9022699","MECP2 regulates neuronal receptors and channels","1/35","12/2914",0.13522025280187,0.240948022482344,0.157566593041815,"HDAC1",1
"R-HSA-190236","R-HSA-190236","Signaling by FGFR","2/35","55/2914",0.14035965217538,0.242563363795555,0.158622936334033,"MAPK3/MAPK1",2
"R-HSA-5696398","R-HSA-5696398","Nucleotide Excision Repair","2/35","55/2914",0.14035965217538,0.242563363795555,0.158622936334033,"PIAS1/PARP1",2
"R-HSA-8953854","R-HSA-8953854","Metabolism of RNA","3/35","109/2914",0.140870931708482,0.242563363795555,0.158622936334033,"MAPKAPK2/CSNK1D/AKT1",3
"R-HSA-166016","R-HSA-166016","Toll Like Receptor 4 (TLR4) Cascade","3/35","110/2914",0.143673529501115,0.242563363795555,0.158622936334033,"MAPK3/MAPK1/MAPKAPK2",3
"R-HSA-68877","R-HSA-68877","Mitotic Prometaphase","2/35","56/2914",0.144502687890122,0.242563363795555,0.158622936334033,"CSNK2A1/CSNK1D",2
"R-HSA-171007","R-HSA-171007","p38MAPK events","1/35","13/2914",0.14565005678255,0.242563363795555,0.158622936334033,"MAPKAPK2",1
"R-HSA-428540","R-HSA-428540","Activation of RAC1","1/35","13/2914",0.14565005678255,0.242563363795555,0.158622936334033,"PAK1",1
"R-HSA-4839735","R-HSA-4839735","AXIN mutants destabilize the destruction complex, activating WNT signaling","1/35","13/2914",0.14565005678255,0.242563363795555,0.158622936334033,"AXIN1",1
"R-HSA-4839744","R-HSA-4839744","truncated APC mutants destabilize the destruction complex","1/35","13/2914",0.14565005678255,0.242563363795555,0.158622936334033,"AXIN1",1
"R-HSA-4839748","R-HSA-4839748","AMER1 mutants destabilize the destruction complex","1/35","13/2914",0.14565005678255,0.242563363795555,0.158622936334033,"AXIN1",1
"R-HSA-5467337","R-HSA-5467337","APC truncation mutants have impaired AXIN binding","1/35","13/2914",0.14565005678255,0.242563363795555,0.158622936334033,"AXIN1",1
"R-HSA-5467340","R-HSA-5467340","AXIN missense mutants destabilize the destruction complex","1/35","13/2914",0.14565005678255,0.242563363795555,0.158622936334033,"AXIN1",1
"R-HSA-5467348","R-HSA-5467348","Truncations of AMER1 destabilize the destruction complex","1/35","13/2914",0.14565005678255,0.242563363795555,0.158622936334033,"AXIN1",1
"R-HSA-6807505","R-HSA-6807505","RNA polymerase II transcribes snRNA genes","1/35","13/2914",0.14565005678255,0.242563363795555,0.158622936334033,"SP1",1
"R-HSA-8964616","R-HSA-8964616","G beta:gamma signalling through CDC42","1/35","13/2914",0.14565005678255,0.242563363795555,0.158622936334033,"PAK1",1
"R-HSA-912446","R-HSA-912446","Meiotic recombination","1/35","13/2914",0.14565005678255,0.242563363795555,0.158622936334033,"CDK2",1
"R-HSA-9614657","R-HSA-9614657","FOXO-mediated transcription of cell death genes","1/35","13/2914",0.14565005678255,0.242563363795555,0.158622936334033,"STK11",1
"R-HSA-2426168","R-HSA-2426168","Activation of gene expression by SREBF (SREBP)","1/35","14/2914",0.155957622453909,0.249186902297204,0.16295436177938,"SP1",1
"R-HSA-381042","R-HSA-381042","PERK regulates gene expression","1/35","14/2914",0.155957622453909,0.249186902297204,0.16295436177938,"CEBPB",1
"R-HSA-445355","R-HSA-445355","Smooth Muscle Contraction","1/35","14/2914",0.155957622453909,0.249186902297204,0.16295436177938,"PAK1",1
"R-HSA-4641257","R-HSA-4641257","Degradation of AXIN","1/35","14/2914",0.155957622453909,0.249186902297204,0.16295436177938,"AXIN1",1
"R-HSA-4839743","R-HSA-4839743","phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex","1/35","14/2914",0.155957622453909,0.249186902297204,0.16295436177938,"AXIN1",1
"R-HSA-5339716","R-HSA-5339716","Misspliced GSK3beta mutants stabilize beta-catenin","1/35","14/2914",0.155957622453909,0.249186902297204,0.16295436177938,"AXIN1",1
"R-HSA-5358747","R-HSA-5358747","S33 mutants of beta-catenin aren't phosphorylated","1/35","14/2914",0.155957622453909,0.249186902297204,0.16295436177938,"AXIN1",1
"R-HSA-5358749","R-HSA-5358749","S37 mutants of beta-catenin aren't phosphorylated","1/35","14/2914",0.155957622453909,0.249186902297204,0.16295436177938,"AXIN1",1
"R-HSA-5358751","R-HSA-5358751","S45 mutants of beta-catenin aren't phosphorylated","1/35","14/2914",0.155957622453909,0.249186902297204,0.16295436177938,"AXIN1",1
"R-HSA-5358752","R-HSA-5358752","T41 mutants of beta-catenin aren't phosphorylated","1/35","14/2914",0.155957622453909,0.249186902297204,0.16295436177938,"AXIN1",1
"R-HSA-8983432","R-HSA-8983432","Interleukin-15 signaling","1/35","14/2914",0.155957622453909,0.249186902297204,0.16295436177938,"STAT3",1
"R-HSA-111885","R-HSA-111885","Opioid Signalling","2/35","59/2914",0.157086803693143,0.250068330879158,0.163530767002537,"CDK5/MAPK1",2
"R-HSA-2028269","R-HSA-2028269","Signaling by Hippo","1/35","15/2914",0.166144340803603,0.258778775424316,0.169226912821542,"YAP1",1
"R-HSA-427413","R-HSA-427413","NoRC negatively regulates rRNA expression","1/35","15/2914",0.166144340803603,0.258778775424316,0.169226912821542,"HDAC1",1
"R-HSA-5250913","R-HSA-5250913","Positive epigenetic regulation of rRNA expression","1/35","15/2914",0.166144340803603,0.258778775424316,0.169226912821542,"HDAC1",1
"R-HSA-8862803","R-HSA-8862803","Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models","1/35","15/2914",0.166144340803603,0.258778775424316,0.169226912821542,"CDK5",1
"R-HSA-8863678","R-HSA-8863678","Neurodegenerative Diseases","1/35","15/2914",0.166144340803603,0.258778775424316,0.169226912821542,"CDK5",1
"R-HSA-9604323","R-HSA-9604323","Negative regulation of NOTCH4 signaling","1/35","15/2914",0.166144340803603,0.258778775424316,0.169226912821542,"AKT1",1
"R-HSA-556833","R-HSA-556833","Metabolism of lipids","3/35","119/2914",0.169724151283933,0.263407016150333,0.172253524600558,"CSNK2A1/SP1/MAPKAPK2",3
"R-HSA-5693538","R-HSA-5693538","Homology Directed Repair","2/35","63/2914",0.174184588115741,0.26492922698756,0.173248965746089,"CDK2/PARP1",2
"R-HSA-176187","R-HSA-176187","Activation of ATR in response to replication stress","1/35","16/2914",0.176211587465167,0.26492922698756,0.173248965746089,"CDK2",1
"R-HSA-196299","R-HSA-196299","Beta-catenin phosphorylation cascade","1/35","16/2914",0.176211587465167,0.26492922698756,0.173248965746089,"AXIN1",1
"R-HSA-3214815","R-HSA-3214815","HDACs deacetylate histones","1/35","16/2914",0.176211587465167,0.26492922698756,0.173248965746089,"HDAC1",1
"R-HSA-3232118","R-HSA-3232118","SUMOylation of transcription factors","1/35","16/2914",0.176211587465167,0.26492922698756,0.173248965746089,"PIAS1",1
"R-HSA-3928664","R-HSA-3928664","Ephrin signaling","1/35","16/2914",0.176211587465167,0.26492922698756,0.173248965746089,"PAK1",1
"R-HSA-5205647","R-HSA-5205647","Mitophagy","1/35","16/2914",0.176211587465167,0.26492922698756,0.173248965746089,"CSNK2A1",1
"R-HSA-5627123","R-HSA-5627123","RHO GTPases activate PAKs","1/35","16/2914",0.176211587465167,0.26492922698756,0.173248965746089,"PAK1",1
"R-HSA-73933","R-HSA-73933","Resolution of Abasic Sites (AP sites)","1/35","16/2914",0.176211587465167,0.26492922698756,0.173248965746089,"PARP1",1
"R-HSA-422475","R-HSA-422475","Axon guidance","5/35","254/2914",0.184564910520077,0.273246077993274,0.178687723301789,"MAPK3/CDK5/MAPK1/CSNK2A1/PAK1",5
"R-HSA-9607240","R-HSA-9607240","FLT3 Signaling","4/35","188/2914",0.186052055684906,0.273246077993274,0.178687723301789,"MAPK3/MAPK1/AKT2/DUSP2",4
"R-HSA-3232142","R-HSA-3232142","SUMOylation of ubiquitinylation proteins","1/35","17/2914",0.186160722882254,0.273246077993274,0.178687723301789,"PIAS1",1
"R-HSA-5250941","R-HSA-5250941","Negative epigenetic regulation of rRNA expression","1/35","17/2914",0.186160722882254,0.273246077993274,0.178687723301789,"HDAC1",1
"R-HSA-5696394","R-HSA-5696394","DNA Damage Recognition in GG-NER","1/35","17/2914",0.186160722882254,0.273246077993274,0.178687723301789,"PARP1",1
"R-HSA-68949","R-HSA-68949","Orc1 removal from chromatin","1/35","17/2914",0.186160722882254,0.273246077993274,0.178687723301789,"CDK2",1
"R-HSA-9013695","R-HSA-9013695","NOTCH4 Intracellular Domain Regulates Transcription","1/35","17/2914",0.186160722882254,0.273246077993274,0.178687723301789,"SMAD3",1
"R-HSA-69275","R-HSA-69275","G2/M Transition","2/35","66/2914",0.187209223779306,0.27385673613662,0.179087059731982,"CDK2/CSNK1D",2
"R-HSA-168898","R-HSA-168898","Toll-like Receptor Cascades","3/35","127/2914",0.193986675940947,0.280082538085879,0.183158387614201,"MAPK3/MAPK1/MAPKAPK2",3
"R-HSA-453274","R-HSA-453274","Mitotic G2-G2/M phases","2/35","68/2914",0.195972871658717,0.280082538085879,0.183158387614201,"CDK2/CSNK1D",2
"R-HSA-202433","R-HSA-202433","Generation of second messenger molecules","1/35","18/2914",0.195993092471181,0.280082538085879,0.183158387614201,"PAK1",1
"R-HSA-380972","R-HSA-380972","Energy dependent regulation of mTOR by LKB1-AMPK","1/35","18/2914",0.195993092471181,0.280082538085879,0.183158387614201,"STK11",1
"R-HSA-69273","R-HSA-69273","Cyclin A/B1/B2 associated events during G2/M transition","1/35","18/2914",0.195993092471181,0.280082538085879,0.183158387614201,"CDK2",1
"R-HSA-8939243","R-HSA-8939243","RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known","1/35","18/2914",0.195993092471181,0.280082538085879,0.183158387614201,"CSNK2A1",1
"R-HSA-9013508","R-HSA-9013508","NOTCH3 Intracellular Domain Regulates Transcription","1/35","18/2914",0.195993092471181,0.280082538085879,0.183158387614201,"STAT1",1
"R-HSA-195258","R-HSA-195258","RHO GTPase Effectors","3/35","130/2914",0.203315169928604,0.289196238949717,0.1891182406162,"MAPK3/MAPK1/PAK1",3
"R-HSA-5621575","R-HSA-5621575","CD209 (DC-SIGN) signaling","1/35","19/2914",0.205710026781785,0.289196238949717,0.1891182406162,"PAK1",1
"R-HSA-6814122","R-HSA-6814122","Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding","1/35","19/2914",0.205710026781785,0.289196238949717,0.1891182406162,"CSNK2A1",1
"R-HSA-73762","R-HSA-73762","RNA Polymerase I Transcription Initiation","1/35","19/2914",0.205710026781785,0.289196238949717,0.1891182406162,"HDAC1",1
"R-HSA-9609507","R-HSA-9609507","Protein localization","1/35","19/2914",0.205710026781785,0.289196238949717,0.1891182406162,"PEX14",1
"R-HSA-1655829","R-HSA-1655829","Regulation of cholesterol biosynthesis by SREBP (SREBF)","1/35","20/2914",0.215312841656616,0.297860895965862,0.194784443940238,"SP1",1
"R-HSA-167044","R-HSA-167044","Signalling to RAS","1/35","20/2914",0.215312841656616,0.297860895965862,0.194784443940238,"MAPKAPK2",1
"R-HSA-199977","R-HSA-199977","ER to Golgi Anterograde Transport","1/35","20/2914",0.215312841656616,0.297860895965862,0.194784443940238,"CSNK1D",1
"R-HSA-437239","R-HSA-437239","Recycling pathway of L1","1/35","20/2914",0.215312841656616,0.297860895965862,0.194784443940238,"MAPK1",1
"R-HSA-8936459","R-HSA-8936459","RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function","1/35","20/2914",0.215312841656616,0.297860895965862,0.194784443940238,"HDAC1",1
"R-HSA-5683057","R-HSA-5683057","MAPK family signaling cascades","4/35","202/2914",0.221412505728259,0.305323614587058,0.199664646466315,"MAPK3/MAPK1/PAK1/DUSP2",4
"R-HSA-450302","R-HSA-450302","activated TAK1 mediates p38 MAPK activation","1/35","21/2914",0.224802838388482,0.308036800703204,0.201438919142244,"MAPKAPK2",1
"R-HSA-73884","R-HSA-73884","Base Excision Repair","1/35","21/2914",0.224802838388482,0.308036800703204,0.201438919142244,"PARP1",1
"R-HSA-1266695","R-HSA-1266695","Interleukin-7 signaling","1/35","22/2914",0.23418130387635,0.311044492571962,0.203405782185141,"STAT3",1
"R-HSA-1500620","R-HSA-1500620","Meiosis","1/35","22/2914",0.23418130387635,0.311044492571962,0.203405782185141,"CDK2",1
"R-HSA-180024","R-HSA-180024","DARPP-32 events","1/35","22/2914",0.23418130387635,0.311044492571962,0.203405782185141,"CDK5",1
"R-HSA-187577","R-HSA-187577","SCF(Skp2)-mediated degradation of p27/p21","1/35","22/2914",0.23418130387635,0.311044492571962,0.203405782185141,"CDK2",1
"R-HSA-201722","R-HSA-201722","Formation of the beta-catenin:TCF transactivating complex","1/35","22/2914",0.23418130387635,0.311044492571962,0.203405782185141,"HDAC1",1
"R-HSA-5696400","R-HSA-5696400","Dual Incision in GG-NER","1/35","22/2914",0.23418130387635,0.311044492571962,0.203405782185141,"PARP1",1
"R-HSA-69563","R-HSA-69563","p53-Dependent G1 DNA Damage Response","1/35","22/2914",0.23418130387635,0.311044492571962,0.203405782185141,"CDK2",1
"R-HSA-69580","R-HSA-69580","p53-Dependent G1/S DNA damage checkpoint","1/35","22/2914",0.23418130387635,0.311044492571962,0.203405782185141,"CDK2",1
"R-HSA-8866654","R-HSA-8866654","E3 ubiquitin ligases ubiquitinate target proteins","1/35","22/2914",0.23418130387635,0.311044492571962,0.203405782185141,"PEX14",1
"R-HSA-9022692","R-HSA-9022692","Regulation of MECP2 expression and activity","1/35","22/2914",0.23418130387635,0.311044492571962,0.203405782185141,"HDAC1",1
"R-HSA-112314","R-HSA-112314","Neurotransmitter receptors and postsynaptic signal transmission","2/35","77/2914",0.235991863808147,0.312490755440145,0.204351557586968,"MAPK3/MAPK1",2
"R-HSA-201451","R-HSA-201451","Signaling by BMP","1/35","23/2914",0.243449510779645,0.319435267174503,0.208892881657813,"SMAD4",1
"R-HSA-69002","R-HSA-69002","DNA Replication Pre-Initiation","1/35","23/2914",0.243449510779645,0.319435267174503,0.208892881657813,"CDK2",1
"R-HSA-948021","R-HSA-948021","Transport to the Golgi and subsequent modification","1/35","23/2914",0.243449510779645,0.319435267174503,0.208892881657813,"CSNK1D",1
"R-HSA-1474165","R-HSA-1474165","Reproduction","1/35","24/2914",0.252608717670932,0.326506193288101,0.213516873695148,"CDK2",1
"R-HSA-2559586","R-HSA-2559586","DNA Damage/Telomere Stress Induced Senescence","1/35","24/2914",0.252608717670932,0.326506193288101,0.213516873695148,"CDK2",1
"R-HSA-5625740","R-HSA-5625740","RHO GTPases activate PKNs","1/35","24/2914",0.252608717670932,0.326506193288101,0.213516873695148,"PAK1",1
"R-HSA-69615","R-HSA-69615","G1/S DNA Damage Checkpoints","1/35","24/2914",0.252608717670932,0.326506193288101,0.213516873695148,"CDK2",1
"R-HSA-912694","R-HSA-912694","Regulation of IFNA signaling","1/35","24/2914",0.252608717670932,0.326506193288101,0.213516873695148,"STAT1",1
"R-HSA-5693532","R-HSA-5693532","DNA Double-Strand Break Repair","2/35","81/2914",0.253973957659164,0.327293820435768,0.21403193800224,"CDK2/PARP1",2
"R-HSA-446652","R-HSA-446652","Interleukin-1 family signaling","2/35","82/2914",0.258479245584488,0.329900651331192,0.21573666028465,"STAT3/SMAD3",2
"R-HSA-354192","R-HSA-354192","Integrin alphaIIb beta3 signaling","1/35","25/2914",0.261660169187028,0.329900651331192,0.21573666028465,"AKT1",1
"R-HSA-380259","R-HSA-380259","Loss of Nlp from mitotic centrosomes","1/35","25/2914",0.261660169187028,0.329900651331192,0.21573666028465,"CSNK1D",1
"R-HSA-380284","R-HSA-380284","Loss of proteins required for interphase microtubule organization from the centrosome","1/35","25/2914",0.261660169187028,0.329900651331192,0.21573666028465,"CSNK1D",1
"R-HSA-8864260","R-HSA-8864260","Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors","1/35","25/2914",0.261660169187028,0.329900651331192,0.21573666028465,"ESR1",1
"R-HSA-9006115","R-HSA-9006115","Signaling by NTRK2 (TRKB)","1/35","25/2914",0.261660169187028,0.329900651331192,0.21573666028465,"CDK5",1
"R-HSA-9006921","R-HSA-9006921","Integrin signaling","1/35","25/2914",0.261660169187028,0.329900651331192,0.21573666028465,"AKT1",1
"R-HSA-388396","R-HSA-388396","GPCR downstream signalling","7/35","436/2914",0.262130451028441,0.329900651331192,0.21573666028465,"MAPK3/CDK5/MAPK1/AKT2/PAK1/AKT3/AKT1",7
"R-HSA-1430728","R-HSA-1430728","Metabolism","5/35","289/2914",0.262853867688825,0.329900651331192,0.21573666028465,"CSNK2A1/STK11/SP1/MAPKAPK2/AKT1",5
"R-HSA-111996","R-HSA-111996","Ca-dependent events","1/35","26/2914",0.270605096178532,0.3357364087258,0.219552920742045,"MAPK1",1
"R-HSA-350054","R-HSA-350054","Notch-HLH transcription pathway","1/35","26/2914",0.270605096178532,0.3357364087258,0.219552920742045,"HDAC1",1
"R-HSA-380320","R-HSA-380320","Recruitment of NuMA to mitotic centrosomes","1/35","26/2914",0.270605096178532,0.3357364087258,0.219552920742045,"CSNK1D",1
"R-HSA-8854518","R-HSA-8854518","AURKA Activation by TPX2","1/35","26/2914",0.270605096178532,0.3357364087258,0.219552920742045,"CSNK1D",1
"R-HSA-76002","R-HSA-76002","Platelet activation, signaling and aggregation","3/35","153/2914",0.277863217974679,0.339964480500786,0.222317844304635,"MAPK3/MAPK1/AKT1",3
"R-HSA-380270","R-HSA-380270","Recruitment of mitotic centrosome proteins and complexes","1/35","27/2914",0.279444715857809,0.339964480500786,0.222317844304635,"CSNK1D",1
"R-HSA-380287","R-HSA-380287","Centrosome maturation","1/35","27/2914",0.279444715857809,0.339964480500786,0.222317844304635,"CSNK1D",1
"R-HSA-5689896","R-HSA-5689896","Ovarian tumor domain proteases","1/35","27/2914",0.279444715857809,0.339964480500786,0.222317844304635,"ESR1",1
"R-HSA-69017","R-HSA-69017","CDK-mediated phosphorylation and removal of Cdc6","1/35","27/2914",0.279444715857809,0.339964480500786,0.222317844304635,"CDK2",1
"R-HSA-8852135","R-HSA-8852135","Protein ubiquitination","1/35","27/2914",0.279444715857809,0.339964480500786,0.222317844304635,"PEX14",1
"R-HSA-1280218","R-HSA-1280218","Adaptive Immune System","5/35","296/2914",0.279508903136905,0.339964480500786,0.222317844304635,"AKT2/PAK1/FBXO22/AKT3/AKT1",5
"R-HSA-112315","R-HSA-112315","Transmission across Chemical Synapses","2/35","88/2914",0.285539382419311,0.346326477836307,0.226478236387423,"MAPK3/MAPK1",2
"R-HSA-5620912","R-HSA-5620912","Anchoring of the basal body to the plasma membrane","1/35","28/2914",0.288180231945435,0.347582285326945,0.227299464575053,"CSNK1D",1
"R-HSA-8957322","R-HSA-8957322","Metabolism of steroids","1/35","28/2914",0.288180231945435,0.347582285326945,0.227299464575053,"SP1",1
"R-HSA-73894","R-HSA-73894","DNA Repair","3/35","157/2914",0.291202926408741,0.350252408708291,0.229045576619741,"CDK2/PIAS1/PARP1",3
"R-HSA-1483257","R-HSA-1483257","Phospholipid metabolism","1/35","30/2914",0.30534370163712,0.365231554720643,0.238841104217462,"CSNK2A1",1
"R-HSA-4641262","R-HSA-4641262","Disassembly of the destruction complex and recruitment of AXIN to the membrane","1/35","30/2914",0.30534370163712,0.365231554720643,0.238841104217462,"AXIN1",1
"R-HSA-196854","R-HSA-196854","Metabolism of vitamins and cofactors","1/35","31/2914",0.313773996520164,0.373253133223163,0.244086769993997,"AKT1",1
"R-HSA-4791275","R-HSA-4791275","Signaling by WNT in cancer","1/35","31/2914",0.313773996520164,0.373253133223163,0.244086769993997,"AXIN1",1
"R-HSA-69052","R-HSA-69052","Switching of origins to a post-replicative state","1/35","33/2914",0.330337462437876,0.390809074414209,0.255567378187486,"CDK2",1
"R-HSA-76009","R-HSA-76009","Platelet Aggregation (Plug Formation)","1/35","33/2914",0.330337462437876,0.390809074414209,0.255567378187486,"AKT1",1
"R-HSA-5673001","R-HSA-5673001","RAF/MAP kinase cascade","3/35","171/2914",0.338259306355431,0.392918940154752,0.256947112924829,"MAPK3/MAPK1/DUSP2",3
"R-HSA-112040","R-HSA-112040","G-protein mediated events","1/35","34/2914",0.338472897639082,0.392918940154752,0.256947112924829,"MAPK1",1
"R-HSA-112043","R-HSA-112043","PLC beta mediated events","1/35","34/2914",0.338472897639082,0.392918940154752,0.256947112924829,"MAPK1",1
"R-HSA-176408","R-HSA-176408","Regulation of APC/C activators between G1/S and early anaphase","1/35","34/2914",0.338472897639082,0.392918940154752,0.256947112924829,"CDK2",1
"R-HSA-3928662","R-HSA-3928662","EPHB-mediated forward signaling","1/35","34/2914",0.338472897639082,0.392918940154752,0.256947112924829,"PAK1",1
"R-HSA-446203","R-HSA-446203","Asparagine N-linked glycosylation","1/35","34/2914",0.338472897639082,0.392918940154752,0.256947112924829,"CSNK1D",1
"R-HSA-5687128","R-HSA-5687128","MAPK6/MAPK4 signaling","1/35","34/2914",0.338472897639082,0.392918940154752,0.256947112924829,"PAK1",1
"R-HSA-373752","R-HSA-373752","Netrin-1 signaling","1/35","35/2914",0.346512289508052,0.401175992933119,0.262346765768832,"PAK1",1
"R-HSA-5684996","R-HSA-5684996","MAPK1/MAPK3 signaling","3/35","177/2914",0.358474048507961,0.412839673286391,0.269974163398661,"MAPK3/MAPK1/DUSP2",3
"R-HSA-112316","R-HSA-112316","Neuronal System","2/35","105/2914",0.361542776374133,0.412839673286391,0.269974163398661,"MAPK3/MAPK1",2
"R-HSA-212165","R-HSA-212165","Epigenetic regulation of gene expression","1/35","37/2914",0.362307334523854,0.412839673286391,0.269974163398661,"HDAC1",1
"R-HSA-2565942","R-HSA-2565942","Regulation of PLK1 Activity at G2/M Transition","1/35","37/2914",0.362307334523854,0.412839673286391,0.269974163398661,"CSNK1D",1
"R-HSA-3899300","R-HSA-3899300","SUMOylation of transcription cofactors","1/35","37/2914",0.362307334523854,0.412839673286391,0.269974163398661,"PIAS1",1
"R-HSA-9012852","R-HSA-9012852","Signaling by NOTCH3","1/35","37/2914",0.362307334523854,0.412839673286391,0.269974163398661,"STAT1",1
"R-HSA-372790","R-HSA-372790","Signaling by GPCR","7/35","486/2914",0.36428950961519,0.414008812764769,0.270738715531112,"MAPK3/CDK5/MAPK1/AKT2/PAK1/AKT3/AKT1",7
"R-HSA-174143","R-HSA-174143","APC/C-mediated degradation of cell cycle proteins","1/35","40/2914",0.385306703969217,0.433344942386158,0.283383467854325,"CDK2",1
"R-HSA-2122947","R-HSA-2122947","NOTCH1 Intracellular Domain Regulates Transcription","1/35","40/2914",0.385306703969217,0.433344942386158,0.283383467854325,"HDAC1",1
"R-HSA-381340","R-HSA-381340","Transcriptional regulation of white adipocyte differentiation","1/35","40/2914",0.385306703969217,0.433344942386158,0.283383467854325,"CEBPB",1
"R-HSA-453276","R-HSA-453276","Regulation of mitotic cell cycle","1/35","40/2914",0.385306703969217,0.433344942386158,0.283383467854325,"CDK2",1
"R-HSA-8986944","R-HSA-8986944","Transcriptional Regulation by MECP2","1/35","41/2914",0.392792530469244,0.440619600241406,0.288140689108881,"HDAC1",1
"R-HSA-109704","R-HSA-109704","PI3K Cascade","1/35","42/2914",0.400189767306548,0.444313254471116,0.290556133348074,"AKT2",1
"R-HSA-5617833","R-HSA-5617833","Cilium Assembly","1/35","42/2914",0.400189767306548,0.444313254471116,0.290556133348074,"CSNK1D",1
"R-HSA-6783783","R-HSA-6783783","Interleukin-10 signaling","1/35","42/2914",0.400189767306548,0.444313254471116,0.290556133348074,"STAT3",1
"R-HSA-909733","R-HSA-909733","Interferon alpha/beta signaling","1/35","42/2914",0.400189767306548,0.444313254471116,0.290556133348074,"STAT1",1
"R-HSA-69239","R-HSA-69239","Synthesis of DNA","1/35","44/2914",0.414722532317077,0.459270732719423,0.300337491434362,"CDK2",1
"R-HSA-112399","R-HSA-112399","IRS-mediated signalling","1/35","46/2914",0.428913006926499,0.472568274807059,0.309033343680804,"AKT2",1
"R-HSA-383280","R-HSA-383280","Nuclear Receptor transcription pathway","1/35","46/2914",0.428913006926499,0.472568274807059,0.309033343680804,"ESR1",1
"R-HSA-1989781","R-HSA-1989781","PPARA activates gene expression","1/35","47/2914",0.435882339129279,0.479028052900959,0.313257678936084,"SP1",1
"R-HSA-400206","R-HSA-400206","Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)","1/35","48/2914",0.442769021421039,0.48413885423058,0.316599858485538,"SP1",1
"R-HSA-5693607","R-HSA-5693607","Processing of DNA double-strand break ends","1/35","48/2914",0.442769021421039,0.48413885423058,0.316599858485538,"CDK2",1
"R-HSA-6798695","R-HSA-6798695","Neutrophil degranulation","2/35","125/2914",0.447254794917566,0.487811904784147,0.319001829067547,"MAPK1/PTPRB",2
"R-HSA-2428928","R-HSA-2428928","IRS-related events triggered by IGF1R","1/35","50/2914",0.456298232267529,0.492516363176306,0.322078282957157,"AKT2",1
"R-HSA-2404192","R-HSA-2404192","Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)","1/35","51/2914",0.462942632362024,0.492516363176306,0.322078282957157,"AKT2",1
"R-HSA-2428924","R-HSA-2428924","IGF1R signaling cascade","1/35","51/2914",0.462942632362024,0.492516363176306,0.322078282957157,"AKT2",1
"R-HSA-2644602","R-HSA-2644602","Signaling by NOTCH1 PEST Domain Mutants in Cancer","1/35","51/2914",0.462942632362024,0.492516363176306,0.322078282957157,"HDAC1",1
"R-HSA-2644603","R-HSA-2644603","Signaling by NOTCH1 in Cancer","1/35","51/2914",0.462942632362024,0.492516363176306,0.322078282957157,"HDAC1",1
"R-HSA-2644606","R-HSA-2644606","Constitutive Signaling by NOTCH1 PEST Domain Mutants","1/35","51/2914",0.462942632362024,0.492516363176306,0.322078282957157,"HDAC1",1
"R-HSA-2894858","R-HSA-2894858","Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer","1/35","51/2914",0.462942632362024,0.492516363176306,0.322078282957157,"HDAC1",1
"R-HSA-2894862","R-HSA-2894862","Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants","1/35","51/2914",0.462942632362024,0.492516363176306,0.322078282957157,"HDAC1",1
"R-HSA-69306","R-HSA-69306","DNA Replication","1/35","51/2914",0.462942632362024,0.492516363176306,0.322078282957157,"CDK2",1
"R-HSA-8951664","R-HSA-8951664","Neddylation","1/35","51/2914",0.462942632362024,0.492516363176306,0.322078282957157,"FBXO22",1
"R-HSA-400253","R-HSA-400253","Circadian Clock","1/35","52/2914",0.469508125853931,0.498277006114589,0.325845422741763,"CSNK1D",1
"R-HSA-1632852","R-HSA-1632852","Macroautophagy","1/35","53/2914",0.475995622567807,0.502697816028928,0.328736386317689,"CSNK2A1",1
"R-HSA-397014","R-HSA-397014","Muscle contraction","1/35","53/2914",0.475995622567807,0.502697816028928,0.328736386317689,"PAK1",1
"R-HSA-163685","R-HSA-163685","Integration of energy metabolism","1/35","55/2914",0.488740214188515,0.514901490860406,0.336716910274582,"STK11",1
"R-HSA-202403","R-HSA-202403","TCR signaling","1/35","59/2914",0.513332352275554,0.53819106182885,0.35194699314929,"PAK1",1
"R-HSA-5693567","R-HSA-5693567","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","1/35","59/2914",0.513332352275554,0.53819106182885,0.35194699314929,"CDK2",1
"R-HSA-194315","R-HSA-194315","Signaling by Rho GTPases","3/35","228/2914",0.524074805942935,0.547973064196251,0.358343878130039,"MAPK3/MAPK1/PAK1",3
"R-HSA-9612973","R-HSA-9612973","Autophagy","1/35","61/2914",0.525193583467539,0.547973064196251,0.358343878130039,"CSNK2A1",1
"R-HSA-6806834","R-HSA-6806834","Signaling by MET","1/35","62/2914",0.531018408065729,0.551393215089834,0.360580466413432,"STAT3",1
"R-HSA-69481","R-HSA-69481","G2/M Checkpoints","1/35","62/2914",0.531018408065729,0.551393215089834,0.360580466413432,"CDK2",1
"R-HSA-1980143","R-HSA-1980143","Signaling by NOTCH1","1/35","64/2914",0.542460539810541,0.560585712978435,0.366591848282969,"HDAC1",1
"R-HSA-376176","R-HSA-376176","Signaling by ROBO receptors","1/35","64/2914",0.542460539810541,0.560585712978435,0.366591848282969,"PAK1",1
"R-HSA-2682334","R-HSA-2682334","EPH-Ephrin signaling","1/35","68/2914",0.564536925097132,0.582010687064424,0.38060258859932,"PAK1",1
"R-HSA-2219530","R-HSA-2219530","Constitutive Signaling by Aberrant PI3K in Cancer","1/35","72/2914",0.585577119669315,0.600840978238895,0.392916550738453,"ESR1",1
"R-HSA-5621481","R-HSA-5621481","C-type lectin receptors (CLRs)","1/35","72/2914",0.585577119669315,0.600840978238895,0.392916550738453,"PAK1",1
"R-HSA-416476","R-HSA-416476","G alpha (q) signalling events","2/35","165/2914",0.598437309812629,0.612584763945315,0.400596332809748,"MAPK3/MAPK1",2
"R-HSA-168249","R-HSA-168249","Innate Immune System","5/35","428/2914",0.600515705678606,0.61326250131801,0.401039535321611,"MAPK3/MAPK1/PAK1/MAPKAPK2/PTPRB",5
"R-HSA-193704","R-HSA-193704","p75 NTR receptor-mediated signalling","1/35","76/2914",0.605628393868229,0.617028457752807,0.403502261177841,"HDAC1",1
"R-HSA-1852241","R-HSA-1852241","Organelle biogenesis and maintenance","1/35","80/2914",0.624735924033736,0.635001537808938,0.415255654966827,"CSNK1D",1
"R-HSA-983168","R-HSA-983168","Antigen processing: Ubiquitination & Proteasome degradation","1/35","88/2914",0.660290523793378,0.669568610778765,0.437860596327915,"FBXO22",1
"R-HSA-73887","R-HSA-73887","Death Receptor Signalling","1/35","106/2914",0.728737477880435,0.737250766173431,0.482120958066496,"HDAC1",1
"R-HSA-3247509","R-HSA-3247509","Chromatin modifying enzymes","1/35","109/2914",0.738758460803526,0.743912589599829,0.486477419721294,"HDAC1",1
"R-HSA-4839726","R-HSA-4839726","Chromatin organization","1/35","109/2914",0.738758460803526,0.743912589599829,0.486477419721294,"HDAC1",1
"R-HSA-418594","R-HSA-418594","G alpha (i) signalling events","2/35","217/2914",0.747537764795844,0.751006617532716,0.491116519062357,"CDK5/MAPK1",2
"R-HSA-69620","R-HSA-69620","Cell Cycle Checkpoints","1/35","114/2914",0.75466632356496,0.75641323635099,0.494652146781126,"CDK2",1
"R-HSA-983169","R-HSA-983169","Class I MHC mediated antigen processing & presentation","1/35","115/2914",0.757732994520398,0.757732994520398,0.495515195152515,"FBXO22",1
